Le Lézard
Classified in: Health
Subjects: PDT, WOM

IQ Medical Ventures rebrands as IQ Women's Health to pioneer innovations in women's Health


ROTTERDAM, Netherlands, June 14, 2024 /PRNewswire/ -- IQ Medical Ventures has rebranded as IQ Women's Health. This strategic transformation underscores the company's commitment to addressing the diverse and unique needs of women in healthcare. Our mission is to accelerate innovation and support the development of groundbreaking solutions that enhance women's health outcomes globally. 

Johan F.M. Remmerswaal, Managing Director at IQ Women's Health

About IQ Women's Health

IQ Women's Health is dedicated to fostering innovation and supporting the development of cutting-edge solutions in women's health. The organization caters to the needs of physicians, start-ups, and investors, providing the resources, network, and regulatory guidance necessary to succeed in advancing women's health outcomes worldwide.

Why women's health

The decision to rebrand and focus on women's health stems from a deeply personal place. Throughout their journey as IQ Medical Ventures, the team has first handedly seen the gaps and opportunities in women's healthcare. The stories of countless women seeking better health solutions, the dedication of physicians striving to provide exceptional care, and the innovative ideas from start-ups looking to make a difference have all inspired the organization. Women's health is not just a market; it is a critical area where innovation can lead to profound improvements in quality of life.

The journey and commitment

Building on extensive experience in the healthcare sector, IQ Women's Health recognizes the critical need for advancements in women's health. The organization is fully dedicated to leading this transformation by providing essential resources, a robust ecosystem, and expert guidance. Whether a healthcare provider with pioneering ideas, a start-up aiming to revolutionize women's health, or an investor seeking impactful opportunities, IQ Women's Health is there to support every stage.

A Personal note from the leadership

"We believe in the power of innovation to transform women's health," said Johan F.M. Remmerswaal, Managing Director at IQ Women's Health. "Our rebranding and renewed focus demonstrate our dedication to advancing healthcare solutions that will have a lasting, positive impact on the lives of women worldwide. Coming from a family with four older sisters, having lost the youngest and her daughter to breast cancer, having listened to the countless complaints about the one-sided trials in our industry; we just want to say we heard you! The personal stories and challenges we've encountered along our journey have reinforced our resolution to make a meaningful difference in this field."

Join IQ Women's Health in advancing women's health

IQ Women's Health invites all stakeholders to join in the mission to advance women's health through innovation and collaboration. Together, a healthier, brighter future for all women can be created.

For more information

For more information about IQ Women's Health and their services, please visit www.iq-womenshealth.com or contact directly at +31 (0)10 261 9100.

Photo: https://mma.prnewswire.com/media/2436574/Johan_FM_Remmerswaal.jpg

 


These press releases may also interest you

at 12:07
The Women in Insurance Cancer Crusade (WICC) took another step closer to its goal of raising $25 million by 2025 at their annual Relay for Life fundraising event, held on June 6th . Nearly 300 people came together for an evening of camaraderie for...

at 12:00
"I wanted to create a simple and attractive way to secure your glasses to your shirt, jacket or other article of clothing," said an inventor, from Port St. Lucie, Fla., "so I invented the EYEGLASS PIN HOLDER. My design enables you to keep your...

at 11:56
Northwest Biotherapeutics ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, reported positive results of voting at the Annual Shareholders Meeting on June 29, 2024. ...

at 11:32
The American Parkinson Disease Association (APDA) is celebrating the President's signing of the National Plan to End Parkinson's Act yesterday, marking the enactment of the first-ever federal legislation dedicated to curing and preventing Parkinson's...

at 11:30
NeuroCytonix, Inc., today announced that on May 27, 2024, its subsidiary NeuroCytonix Mexico received a regulatory approval letter from the ethical, scientific, and safety committees of Hospital La Mision in Monterrey, Mexico, to launch a clinical...

at 11:00
States with high rates of COVID-19 vaccination saw more pediatric asthma patients get a break from their symptoms, according to new research published today in JAMA Network Open by leaders from Nemours Children's Health and Endeavor Health....



News published on and distributed by: